trial · primary record
4SCAR-PSMA
Bladder Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Overall Survival rate after receiving 4SCART infusion |
| Registry ID | NCT03185468 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:51.649Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03185468
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.